• CAR T Cells and T-Cell Therapies for Cancer

  • Nov 4 2024
  • Length: 18 mins
  • Podcast

CAR T Cells and T-Cell Therapies for Cancer

Listen for free

View show details

  • Summary

  • CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.”

    Related Content:

    • CAR T Cells and T-Cell Therapies for Cancer
    • Translational Science Reviews—A New JAMA Review
    Show More Show Less
Show More Show Less

What listeners say about CAR T Cells and T-Cell Therapies for Cancer

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.